Vascular Biogenics (NASDAQ:VBLT) Coverage Initiated by Analy

StockNews.com assumed coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a report issued on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Performance Shares of NASDAQ VBLT opened at $0.16 on Monday. Vascular Biogenics has a fifty-two week low of $0.10 and a fifty-two week […]

Related Keywords

United States , Israel , , Envestnet Asset Management Inc , Medicard Ltd , Advisor Group Holdings Inc , Vascular Biogenics Ltd , Renaissance Technologies , Vascular Biogenics , Free Report , Get Free Report , Asset Management , Sigma Investments , Advisor Group Holdings , Group Holdings , Biogenics Ltd , Vascular Biogenics Daily , Nasdaq Vblt , Vblt , Medical , Initiated Coverage , Stocknews Com ,